[Cost-effectiveness of antiviral therapy for chronic hepatitis C patients in prevention of hepatocellular cancer]

MeSH terms

• Adult
• Age Factors
• Aged
• Antiviral Agents / economics*
• Antiviral Agents / therapeutic use*
• Carcinoma, Hepatocellular / economics*
• Carcinoma, Hepatocellular / epidemiology
• Carcinoma, Hepatocellular / prevention & control*
• Cohort Studies
• Cost-Benefit Analysis*
• Female
• Fibrosis
• Hepatitis C, Chronic / complications
• Hepatitis C, Chronic / drug therapy*
• Hepatitis C, Chronic / economics*
• Hepatitis C, Chronic / pathology
• Humans
• Interferons / economics*
• Interferons / therapeutic use*
• Liver / pathology
• Liver Neoplasms / economics*
• Liver Neoplasms / epidemiology
• Liver Neoplasms / prevention & control*
• Male
• Middle Aged
• Risk
• Survival Rate